Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in VSports app下载. gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

. 2013 Oct 16;8(10):e78146.
doi: 10.1371/journal.pone.0078146. eCollection 2013.

VSports在线直播 - Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers

Affiliations

Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers

Mohammad-Ali Jenabian et al. PLoS One. .

Erratum in

  • PLoS One. 2014;9(1). doi:10.1371/annotation/11698dd2-0bc1-4fe0-ad92-b161b5594e81

Abstract

Tryptophan (Trp) catabolism into immunosuppressive kynurenine (Kyn) by indoleamine 2,3-dioxygenase (IDO) was previously linked to Th17/Treg differentiation and immune activation. Here we examined Trp catabolism and its impact on Th17/Treg balance in uninfected healthy subjects (HS) and a large cohort of HIV-infected patients with different clinical outcomes: ART-naïve, Successfully Treated (ST), and elite controllers (EC). In ART-naïve patients, increased IDO activity/expression, together with elevated levels of TNF-α and sCD40L, were associated with Treg expansion and an altered Th17/Treg balance. These alterations were normalized under ART. In contrast, Trp 2,3-dioxegenase (TDO) expression was dramatically lower in EC when compared to all other groups. Interestingly, EC displayed a distinctive Trp metabolism characterized by low Trp plasma levels similar to ART-naïve patients without accumulating immunosuppressive Kyn levels which was accompanied by a preserved Th17/Treg balance. These results suggest a distinctive Trp catabolism and Th17/Treg balance in HIV progressors and EC. Thus, IDO-induced immune-metabolism may be considered as a new inflammation-related marker for HIV-1 disease progression. VSports手机版.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Tryptophan catabolism is elevated in HIV-infected subjects with disease progression but not elite controllers.
Plasma levels of (A) tryptophan (Trp), (B) kynurenine (Kyn), (C) and 3 -hydroxykynurenine were measured by XLC-MS/MS in ART-successfully treated (ST, n=88), ART-naïve (n=96), elite controllers (EC, n=19), and healthy subjects (HS, n=50), (D) IDO activity in shown, defined as the Kyn/Trp ratio. Statistical analysis was provided by ANOVA tests followed by unpaired t-tests used for comparison of two variables.
Figure 2
Figure 2. Tryptophan catabolites are associated with higher HIV-1 viral load (VL) and lower CD4+ T-cell counts in ART-naïve patients.
Association between plasmatic HIV-1 viral load and plasmatic (A) tryptophan (Trp) (B) kynurenine (Kyn) (C) 3-hydroxykynurenine (3OH-Kyn) and (D) IDO activity as defined by Kyn/Trp and CD4+ T-cell counts and plasmatic (E) tryptophan (F) kynurenine (G) 3-hydroxykynurenine and (H) IDO activity (Kyn/Trp ratio) in ART-naïve patients (n=96). Pearson rank correlation was used for statistical analysis.
Figure 3
Figure 3. Th17/Treg imbalance in HIV-1 infection correlates with IDO enzyme activity.
(A) Th17 cells (CD4+IL-17+) frequency in study groups following PMA/Ionomycine in vitro Stimulation (B) Frequency of Treg (CD4+CD25highCD127lowFoxP3high cells) in study groups ex vivo . (C) Th17/Treg ratio in study groups. (C) Th17/Treg ratio in study groups. (D) Correlation between IDO enzymatic activity defined by Trp/Kyn ratio and Th17/Treg ratio in study groups. (E) Association between IDO enzymatic activity and Treg frequency in study groups. (F) Correlation between bacterial translocation marker sCD14 and Th17/Treg ratio in study groups. ST: ART-successfully treated, ART-naïve, EC: elite controllers, and HS: healthy subjects. n=14 per study group. Statistical analysis was provided by Kruskal-Wallis test followed by Mann-Whitney U test for comparison of two variables.
Figure 4
Figure 4. Trp catabolizing enzyme IDO-1 mRNA expression is associated with Treg frequency in HIV-1 infected patients with different clinical outcomes.
(A) Real-time quantitative RT-PCR was used to quantify IDO-1 mRNA and (B) TDO expression relative to the 18s ribosomal RNA from PBMCs of study groups. (C) Association between IDO enzymatic activity and Treg frequency in study groups. ST: ART-successfully treated, ART-naïve, EC: elite controllers, and HS: healthy subjects. N=14 per study group. Statistical analysis was provided by Kruskal-Wallis test followed by Mann-Whitney U test for comparison of two variables. Pearson rank test was used for the correlation.
Figure 5
Figure 5. Correlations between IDO enzymatic activity and levels of inflammatory soluble factors implicated in IDO induction.
Associations between IDO activity (Kyn/Trp ratio) and plasmatic levels of (A) IL-1β (B) IFNγ (C) sCD40L (D) TNF-α and (E) IL-6 in ST: ART-successfully treated, ART-naïve, EC: elite controllers, and HS: healthy subjects. n=14 per study group. Pearson rank correlation was used for statistical analysis.

References

    1. Nixon DE, Landay AL (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5: 498-503. doi:10.1097/COH.0b013e32833ed6f4. PubMed: 20978393. - DOI - PMC - PubMed
    1. Favre D, Mold J, Hunt PW, Kanwar B, Loke P et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36 PubMed: 20484731 (VSports手机版). - PMC - PubMed
    1. Hryniewicz A, Boasso A, Edghill-Smith Y, Vaccari M, Fuchs D et al. (2006) CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 108: 3834-3842. doi:10.1182/blood-2006-04-010637. PubMed: 16896154. - DOI - PMC - PubMed
    1. Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME et al. (2008) Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc Natl Acad Sci U S A 105: 17073-17078. doi:10.1073/pnas.0806173105. PubMed: 18952840. - DOI - PMC - PubMed
    1. Godin-Ethier J, Hanafi LA, Piccirillo CA, Lapointe R (2011) Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clin Cancer Res 17: 6985-6991. doi:10.1158/1078-0432.CCR-11-1331. PubMed: 22068654. - DOI - PubMed

Publication types

"V体育安卓版" MeSH terms